Persistent delta antigenaemia in chronic delta hepatitis and its relation with human immunodeficiency virus infection
✍ Scribed by Dr. Philippe Roingeard; Frédéric Dubois; Patrick Marcellin; Jacques Bernuau; Sylvie Bonduelle; Jean-Pierre Benhamou; Alain Goudeau
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 339 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The prevalence of persistent hepatitis delta (HD) antigenaemia and associated factors in patients with chronic infection with the hepatitis delta virus (HDV) were investigated. Among 157 consecutive patients known to be carriers of hepatitis B surface antigen (HBsAg), 36 (23%) had one serum marker of HDV infection (anti‐HD and/or HDAg). Nine of the patients with an HDV marker were HDAg positive, including three who were anti‐HD negative. A follow‐up over a mean period of 13 months showed that five of five patients had a persistent HD antigenaemia. This serological profile was associated with the presence of antibody to the human immunodeficiency virus (anti‐HIV) (P < 0.01), serum HIV antigen (HlVAg) (P < 0.21, and the female sex (P < 0.05). Persistent HD antigenaemia could be the consequence of the suppression of T cell cytotoxic activity against hepatocytes expressing HDAg, a lower humoral response, and/or hormonal factors. © 1992 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Eighty-six patients were followed for 6.5 years to study the epidemiological, virological, and histological course of chronic delta hepatitis and the relationship of this disease with HIV and HCV infection. Patients were classified into four groups according to simultaneous HCV and/or HIV infection
## Abstract Since hepatitis C virus (HCV) and hepatitis delta virus (HDV) are transmitted by the same routes as hepatitis B virus (HBV), simultaneous or concurrent HCV and HDV infection in patients with chronic HBV infection may occur. To test this hypothesis and to examine the clinicohistological
## Abstract The aim of this study was to evaluate whether patients with chronic hepatitis delta virus (HDV) infection treated with alpha interferon and subsequent loss of hepatitis B surface antigen (HBsAg) eliminate HDV. HDV RNA was detected in 26 of 28 patients with chronic delta hepatitis using
## Abstract Four woodchucks chronically infected with hepatitis delta virus (HDV) were treated with cyclosporin‐A (CyA) for 11 weeks. All animals had detectable HDAg in the liver and two of them were also positive for HDAg and HDV‐RNA in serum. Reappearance of HDV in serum was noted in one of the t
## Abstract IgM, IgG, and HBsAg containing circulating immune complexes (CIC) were determined, by conglutinin (K) and C1q assays, for assessing the role of CIC in hepatitis delta virus (HDV) infection in 54 HBsAg‐negative controls and 85 HBsAg‐positive patients with chronic hepatitis. The prevalenc